Inhaled Mometasone Furoate Improves Health-Related Quality of Life in Patients with Persistent Asthma

References

• Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004; 59: 469–478
   PubMed Web of Science ®Google Scholar
• National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. 2007, Available at: http://www.nhlbi.nih.gov/guidelines/asthma/asthupdt.htm Accessed August 29, 2007
   Google Scholar
• Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention, revised 2006. National Heart, Lung, and Blood Institute, Available at: http://www.ginasthma.com/Guidelineitem.asp??l1=2&l2=1&intId=60 Accessed December 6, 2006
   Google Scholar
• Juniper E F, Wisniewski M E, Cox F M, Emmett A H, Nielsen K E, O'Byrne P M. Relationship between quality of life and clinical status in asthma: a factor analysis. Eur Respir J 2004; 23: 287–291
   PubMed Web of Science ®Google Scholar
• Chen H, Gould M K, Blanc P D, Miller D P, Kamath T V, Lee J H, Sullivan S D, for the TENOR Study Group. Asthma control, severity, and quality of life: Quantifying the effect of uncontrolled disease. J Allergy Clin Immunol 2007; 120: 396–402
   PubMed Web of Science ®Google Scholar
• Moy M L, Israel E, Weiss S T, Juniper E F, Dube L, Drazen J M. Clinical predictors of health-related quality of life depend on asthma severity. Am J Respir Crit Care Med 2001; 163: 924–929
   PubMed Web of Science ®Google Scholar
• Schatz M, Mosen D, Apter A J, Zeiger R S, Vollmer W M, Stibolt T B, Leong A, Johnson M S, Mendoza G, Cook E F. Relationships among quality of life, severity, and control measures in asthma: an evaluation using factor analysis. J Allergy Clin Immunol 2005; 115: 1049–1055
   PubMed Web of Science ®Google Scholar
• King M T, Hall J, Lancsar E, Fiebig D, Hossain I, Louviere J, Reddel H K, Jenkins C R. Patient preferences for managing asthma: Results from a discrete choice experiment. Health Econ 2007; 16: 703–717
   PubMed Web of Science ®Google Scholar
• Leynaert B, Neukirch C, Liard R, Bousquet J, Neukirch F. Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am J Respir Crit Care Med 2000; 162: 1391–1396
   PubMed Web of Science ®Google Scholar
• Laforest L, Pacheco Y, Bartsch P, Vincken W, Pietri G, Ernst P, Berard A, Van Ganse E. Correlates of quality of life in patients with asthma. Ann Allergy Asthma Immunol 2005; 94: 473–479
   PubMed Web of Science ®Google Scholar
• Rutten-van Molken M P, Custers F, van Doorslaer E K, Jansen C C, Heurman L, Maesen F P, Smeets J J, Bommer A M, Raaijmakers J A. Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life. Eur Respir J 1995; 8: 888–898
   PubMed Web of Science ®Google Scholar
• Juniper E F, Norman G R, Cox F M, Roberts J N. Comparison of the standard gamble, rating scale, AQLQ and SF-36 for measuring quality of life in asthma. Eur Respir J 2001; 18: 38–44
   PubMed Web of Science ®Google Scholar
• Asmanex Twisthaler (mometasone furoate inhalation powder). Full Prescribing Information. Schering Corporation, Kenilworth, NJ 2005
   Google Scholar
• Nayak A S, Banov C, Corren J, Feinstein B K, Floreani A, Friedman B F, Goldsobel A, Gottschlich G M, Hannaway P J, Lampl K L, Lapidus R J, Lawrence M, Lumry W, Munk Z, Pearlman D, Scardella A T, Schenkel E J, Segal A T, Segall N, Silverman B, Shneyer L, Nolop K B, Harrison J E. Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma. Ann Allergy Asthma Immunol 2000; 84: 417–424
   PubMed Web of Science ®Google Scholar
• Kemp J P, Berkowitz R B, Miller S D, Murray J J, Nolop K, Harrison J E. Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma. J Allergy Clin Immunol 2000; 106: 485–492
   PubMed Web of Science ®Google Scholar
• Fish J E, Karpel J P, Craig T J, Bensch G W, Noonan M, Webb D R, Silverman B, Schenkel E J, Rooklin A R, Ramsdell J W, Nathan R, Leflein J G, Grossman J, Graft D F, Gower R G, Garay S M, Frigas E, Degraff A C, Bronsky E A, Bernstein D I, Berger W, Shneyer L, Nolop K B, Harrison J E. Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma. J Allergy Clin Immunol 2000; 106: 852–860
   PubMed Web of Science ®Google Scholar
• Noonan M, Karpel J P, Bensch G W, Ramsdell J W, Webb D R, Nolop K B, Lutsky B N. Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler. Ann Allergy Asthma Immunol 2001; 86: 36–43
   PubMed Web of Science ®Google Scholar
• Karpel J P, Busse W W, Noonan M J, Monahan M E, Lutsky B, Staudinger H. Effects of mometasone furoate given once daily in the evening on lung function and symptom control in persistent asthma. Ann Pharmacother 2005; 39: 1977–1983
   PubMed Web of Science ®Google Scholar
• D'Urzo A, Karpel J P, Busse W W, Boulet L P, Monahan M E, Lutsky B, Staudinger H. Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids. Curr Med Res Opin 2005; 21: 1281–1289
   PubMed Web of Science ®Google Scholar
• Bensch G W, Prenner B, Berkowitz R, Galant S, Ramsdell J, Lutsky B. Once-daily evening administration of mometasone furoate in asthma treatment initiation. Ann Allergy Asthma Immunol 2006; 96: 533–540
   PubMed Web of Science ®Google Scholar
• Bernstein D I, Berkowitz R B, Chervinsky P, Dvorin D J, Finn A F, Gross G N, Karetzky M, Kemp J P, Laforce C, Lumry W, Mendelson L M, Nelson H, Pearlman D, Rachelefsky G, Ratner P, Repsher L, Segal A T, Selner J C, Settipane G A, Wanderer A, Cuss F M, Nolop K B, Harrison J E. Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler. Respir Med 1999; 93: 603–612
   PubMed Web of Science ®Google Scholar
• Bousquet J, D'Urzo A, Hebert J, Barraza C H, Boulet L P, Suarez-Chacon R, Harnest U, Lundback B, Martinez Morales G, Nieminen M M, Nolop K B, Visser S, Lutsky B N. Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler. Eur Respir J 2000; 16: 808–816
   PubMed Web of Science ®Google Scholar
• Nathan R A, Nayak A S, Graft D F, Lawrence M, Picone F J, Ahmed T, Wolfe J, Vanderwalker M L, Nolop K B, Harrison J E. Mometasone furoate: efficacy and safety in moderate asthma compared with beclomethasone dipropionate. Ann Allergy Asthma Immunol 2001; 86: 203–210
   PubMed Web of Science ®Google Scholar
• O'Connor B, Bonnaud G, Haahtela T, Luna J M, Querfurt H, Wegener T, Lutsky B N. Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator. Ann Allergy Asthma Immunol 2001; 86: 397–404
   PubMed Web of Science ®Google Scholar
• Wardlaw A, Larivee P, Eller J, Cockcroft D W, Ghaly L, Harris A G. Efficacy and safety of mometasone furoate dry powder inhaler vs fluticasone propionate metered-dose inhaler in asthma subjects previously using fluticasone propionate. Ann Allergy Asthma Immunol 2004; 93: 49–55
   PubMed Web of Science ®Google Scholar
• Corren J, Berkowitz R, Murray J J, Prenner B. Comparison of once-daily mometasone furoate versus once-daily budesonide in patients with moderate persistent asthma. Int J Clin Pract 2003; 57: 567–572
   PubMed Web of Science ®Google Scholar
• Iskedjian M, Einarson T R, MacKeigan L D, Shear N, Addis A, Mittmann N, Ilersich A L. Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis. Clin Ther 2002; 24: 302–316
   PubMed Web of Science ®Google Scholar
• Claxton A J, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001; 23: 1296–1310
   PubMed Web of Science ®Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353: 487–497
   PubMed Web of Science ®Google Scholar
• Karpel J P, Nayak A, Lumry W, Craig T J, Kerwin E, Fish J E, Lutsky B. Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma. Respir Med 2007; 101: 628–637
   PubMed Web of Science ®Google Scholar
• Karpel J P, Nelson H. Mometasone furoate dry powder inhaler: a once-daily inhaled corticosteroid for the treatment of persistent asthma. Curr Med Res Opin 2007; 23: 2897–2911
   PubMed Web of Science ®Google Scholar
• Ware J E, Kosinski M, Keller S D. SF-36 Physical and Mental Health Summary Scales: A User's Manual. The Health Institute, New England Medical Center, Boston, MA 1994, Chapter 4
   Google Scholar
• Marks G B, Dunn S M, Woolcock A J. A scale for the measurement of quality of life in adults with asthma. J Clin Epidemiol 1992; 45: 461–472
   PubMed Web of Science ®Google Scholar
• Juniper E F, Guyatt G H, Epstein R S, Ferrie P J, Jaeschke R, Hiller T K. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992; 47: 76–83
   PubMed Web of Science ®Google Scholar
• Bateman E D, Frith L F, Braunstein G L. Achieving guideline-based asthma control: does the patient benefit?. Eur Respir J 2002; 20: 588–595
   PubMed Web of Science ®Google Scholar
• Juniper E F, Svensson K, O'Byrne P M, Barnes P J, Bauer C A, Lofdahl C G, Postma D S, Pauwels R A, Tattersfield A E, Ullman A. Asthma quality of life during 1 year of treatment with budesonide with or without formoterol. Eur Respir J 1999; 14: 1038–1043
   PubMed Web of Science ®Google Scholar
• Nelson H S, Busse W W, de Boisblanc B P, Berger W E, Noonan M J, Webb D R, Wolford J P, Mahajan P S, Hamedani A G, Shah T, Harding S M. Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma. J Allergy Clin Immunol 1999; 103: 267–275
   PubMedGoogle Scholar
• Meltzer E O, Lockey R F, Friedman B F, Kalberg C, Goode-Sellers S, Srebro S, Edwards L, Rickard K. Efficacy and safety of low-dose fluticasone propionate compared with montelukast for maintenance treatment of persistent asthma. Mayo Clin Proc 2002; 77: 437–445
   PubMed Web of Science ®Google Scholar
• Metzger W J, Hampel F C, Jr., Sugar M. Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) is effective and safe in adults previously treated with inhaled corticosteroids. J Asthma 2002; 39: 65–75
   PubMedGoogle Scholar
• Banov C, Howland W C, 3rd, Lumry W R, Parasuraman B, Uryniak T, Liljas B. Budesonide turbuhaler delivered once daily improves health-related quality of life in adult patients with non-steroid-dependent asthma. Allergy Asthma Proc 2003; 24: 129–136
   PubMed Web of Science ®Google Scholar
• Juniper E F, Buist A S. Health-related quality of life in moderate asthma: 400 microg hydrofluoroalkane beclomethasone dipropionate vs 800 microg chlorofluorocarbon beclomethasone dipropionate. The Study Group. Chest 1999; 116: 1297–1303
   PubMed Web of Science ®Google Scholar
• Guyatt G H, Feeny D H, Patrick D L. Measuring health-related quality of life. Ann Intern Med 1993; 118: 622–629
   PubMed Web of Science ®Google Scholar
• Mahajan P, Okamoto L J, Schaberg A, Kellerman D, Schoenwetter W F. Impact of fluticasone propionate powder on health-related quality of life in patients with moderate asthma. J Asthma 1997; 34: 227–234
   PubMed Web of Science ®Google Scholar
• Wyrwich K W, Nelson H S, Tierney W M, Babu A N, Kroenke K, Wolinsky F D. Clinically important differences in health-related quality of life for patients with asthma: an expert consensus panel report. Ann Allergy Asthma Immunol 2003; 91: 148–153
   PubMed Web of Science ®Google Scholar
• Reddel H K, Jenkins C R, Marks G B, Ware S I, Xuan W, Salome C M, Badcock C A, Woolcock A J. Optimal asthma control, starting with high doses of inhaled budesonide. Eur Respir J 2000; 16: 226–235
   PubMed Web of Science ®Google Scholar